{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:02:19Z","timestamp":1789905739042,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Co","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.vhri.2026.101687","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:10:08Z","timestamp":1787083808000},"page":"101687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epidemiology, Patient Characteristics, Treatment Patterns, and Costs of Mild Cognitive Impairment and Alzheimer\u2019s Disease in Taiwan"],"prefix":"10.1016","volume":"58","author":[{"given":"Chaur-Jong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao Hsien","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce C.M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Pei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Newson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hsiun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.vhri.2026.101687_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015527","article-title":"Development of Alzheimer disease in old major depressive patients based upon their health status: a retrospective study in Taiwan","volume":"98","author":"Tao","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"24","key":"10.1016\/j.vhri.2026.101687_bib2","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.vhri.2026.101687_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/CEOR.S93323","article-title":"The epidemiology and burden of Alzheimer\u2019s disease in Taiwan utilizing data from the National Health Insurance Research Database","volume":"8","author":"Hung","year":"2016","journal-title":"Clin Outcomes Res"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/ADR-210310","article-title":"Assessment of high risk for Alzheimer\u2019s disease using plasma biomarkers in subjects with normal cognition in Taiwan: a preliminary study","volume":"5","author":"Hu","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"issue":"8","key":"10.1016\/j.vhri.2026.101687_bib5","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/biomedicines12081675","article-title":"From mild cognitive impairment to dementia: the impact of comorbid conditions on disease conversion","volume":"12","author":"Menegon","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer\u2019s disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.vhri.2026.101687_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/jcm13020518","article-title":"Mild cognitive impairment progression and Alzheimer\u2019s disease risk: a comprehensive analysis of 3553 cases over 203 months","volume":"13","author":"\u00d6ks\u00fcz","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40520-022-02277-8","article-title":"Relieving care burden and promoting health-related quality of life for family caregivers of elderly people with Alzheimer\u2019s disease via an empowerment program","volume":"35","author":"Yazdanmanesh","year":"2022","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"10.1016\/j.vhri.2026.101687_bib9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3233\/JAD-170786","article-title":"Medical comorbidity in Alzheimer\u2019s disease: a nested case-control study","volume":"63","author":"Wang","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-181060","article-title":"Estimating life expectancy and lifetime healthcare costs for Alzheimer\u2019s disease in Taiwan: does the age of disease onset matter?","volume":"73","author":"Yeh","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.vhri.2026.101687_bib11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1212\/CON.0000000000001503","article-title":"Treatment of Alzheimer disease","volume":"30","author":"Geldmacher","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"issue":"6","key":"10.1016\/j.vhri.2026.101687_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3111\/13696998.2015.1014090","article-title":"Medical management, costs, and consequences of Alzheimer\u2019s disease in Germany: an analysis of health claims data","volume":"18","author":"Br\u00fcggenj\u00fcrgen","year":"2015","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.vhri.2026.101687_bib13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/ene.13361","article-title":"Utilization of Western medicine and traditional Chinese medicine among patients with Alzheimer\u2019s disease in Taiwan: a nationwide population-based study","volume":"24","author":"Lai","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.vhri.2026.101687_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5378540","article-title":"Gender and age differences and the trend in the incidence and prevalence of dementia and Alzheimer\u2019s disease in Taiwan: a 7-year national population-based study","volume":"2019","author":"Liu","year":"2019","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.vhri.2026.101687_bib15","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018062","article-title":"Data resource profile: the National Health Insurance Research Database (NHIRD)","volume":"40","author":"Lin","year":"2018","journal-title":"Epidemiol Health"},{"issue":"6","key":"10.1016\/j.vhri.2026.101687_bib16","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/jcm11061554","article-title":"A nationwide survey of dementia prevalence in long-term care facilities in Taiwan","volume":"11","author":"Kao","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.vhri.2026.101687_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vhri.2026.101687_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1425442","article-title":"Non-adherence to antidementia medications and associated factors: a study of Spanish population-based registry data","volume":"15","author":"Guti\u00e9rrez-Abej\u00f3n","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vhri.2026.101687_bib20","first-page":"1","article-title":"Cost of care for Alzheimer\u2019s disease and related dementias in the United States: 2016 to 2060","volume":"10","author":"Nandi","year":"2024","journal-title":"NPJ Aging. Nature"},{"issue":"42","key":"10.1016\/j.vhri.2026.101687_bib21","doi-asserted-by":"crossref","first-page":"E1446","DOI":"10.1503\/cmaj.230595","article-title":"Disease-modifying drugs for Alzheimer disease: implications for people in Canada","volume":"195","author":"Watt","year":"2023","journal-title":"C Can Med Assoc J"},{"issue":"7300","key":"10.1016\/j.vhri.2026.101687_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer\u2019s disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vhri.2026.101687_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/gerona\/gly045","article-title":"Midlife systemic inflammation is associated with frailty in later life: the ARIC study","volume":"74","author":"Walker","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-019-04977-9","article-title":"Cognitive dysfunction in diabetes: how to implement emerging guidelines","volume":"63","author":"Biessels","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.vhri.2026.101687_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/367516","article-title":"Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia","volume":"2012","author":"De La Torre","year":"2012","journal-title":"Cardiovasc Psychiatry Neurol"},{"issue":"2","key":"10.1016\/j.vhri.2026.101687_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.1986.tb04634.x","article-title":"Survival and cause of death in Alzheimer\u2019s disease and multi-infarct dementia","volume":"74","author":"M\u00f6ls\u00e4","year":"1986","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 1","key":"10.1016\/j.vhri.2026.101687_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.archger.2009.09.035","article-title":"Life expectancy in Alzheimer\u2019s disease (AD)","volume":"49","author":"Zanetti","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000265553","article-title":"Very mild to severe dementia and mortality: a 14-year follow-up\u2014the Odense study","volume":"29","author":"Andersen","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"11","key":"10.1016\/j.vhri.2026.101687_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206508","article-title":"The estimated cost of dementia in Japan, the most aged society in the world","volume":"13","author":"Sado","year":"2018","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.vhri.2026.101687_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-016-0371-6","article-title":"Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer\u2019s disease: 18-month UK results from the GERAS observational study","volume":"16","author":"Lenox-Smith","year":"2016","journal-title":"BMC Geriatr"},{"issue":"12","key":"10.1016\/j.vhri.2026.101687_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030379","article-title":"Czech Brain Aging Study (CBAS): prospective multicentre cohort study on risk and protective factors for dementia in the Czech Republic","volume":"9","author":"Sheardova","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.vhri.2026.101687_bib32","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s41669-023-00440-z","article-title":"Cost-effectiveness of non-pharmacological interventions for mild cognitive impairment and dementia: a systematic review of economic evaluations and a review of reviews","volume":"7","author":"Eaglestone","year":"2023","journal-title":"Pharmacoecon Open"},{"issue":"9","key":"10.1016\/j.vhri.2026.101687_bib33","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1002\/alz.12964","article-title":"Cost effectiveness of non-drug interventions that reduce nursing home admissions for people living with dementia","volume":"19","author":"Jutkowitz","year":"2023","journal-title":"Alzheimers Dement"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109926001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:50:31Z","timestamp":1789905031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109926001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":32,"alternative-id":["S2212109926001020"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101687","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, Patient Characteristics, Treatment Patterns, and Costs of Mild Cognitive Impairment and Alzheimer\u2019s Disease in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2026.101687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101687"}}